What is gabapentin used for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gabapentin Uses in Clinical Practice

Gabapentin is primarily used to treat neuropathic pain conditions (particularly postherpetic neuralgia and diabetic peripheral neuropathy), as well as adjunctive therapy for partial onset seizures in adults and children 3 years and older with epilepsy. 1

FDA-Approved Indications

  • Management of postherpetic neuralgia in adults 1
  • Adjunctive therapy for partial onset seizures (with or without secondary generalization) in adults and children 3 years and older with epilepsy 1

Neuropathic Pain Applications

Gabapentin is well-established as a treatment for various neuropathic pain conditions:

Diabetic Peripheral Neuropathy

  • Binds to the α-2-δ subunit of calcium channels, reducing calcium influx and decreasing neurotransmitter release in hyperexcited neurons 2
  • Provides substantial pain relief (at least 50% reduction) in 38% of patients with painful diabetic neuropathy compared to 21% with placebo 3
  • Typical doses range from 1200-3600 mg/day, though clinical practice often uses lower doses than those in clinical trials 2

Postherpetic Neuralgia

  • Provides substantial pain relief in 32% of patients compared to 17% with placebo 3
  • Recommended as a first-line oral treatment for this condition 2

HIV-Associated Neuropathic Pain

  • Recommended as first-line oral pharmacological treatment for chronic HIV-associated neuropathic pain 2
  • May reduce HIV-associated sensory neuropathies through central allodynic effects and inhibition of ectopic discharge activity from injured nerves 2

Other Clinical Applications

Erythromelalgia

  • Used with varying success in treating erythromelalgia (a rare vascular pain disorder) 2
  • All 16 patients in one survey reported improvement with gabapentin, though none experienced complete remission 2

Hot Flashes

  • Effective in moderating both severity and duration of hot flashes 2
  • In a double-blinded, placebo-controlled study of women with breast cancer, higher-dose gabapentin (900 mg/day) reduced hot flash severity by 46-49% compared to 15-21% with placebo 2

Psychiatric Conditions

  • Used in bipolar disorder and other psychiatric conditions, though this is not an FDA-approved indication 4

Dosing Considerations

  • Starting dose typically 300 mg on day 1,600 mg on day 2, and 900 mg on day 3 5
  • Titration to 1800 mg/day recommended for greater efficacy 5
  • Doses up to 3600 mg/day may be needed in some patients 5
  • Elderly patients and those with renal impairment require dose adjustments 6

Adverse Effects

Common side effects include:

  • Dizziness (19% of patients) 3
  • Somnolence (14%) 3
  • Peripheral edema (7%) 3
  • Gait disturbance (14%) 3

Important Considerations

Discontinuation

  • Never stop gabapentin abruptly as this can cause withdrawal symptoms including pruritus, restlessness, confusion, agitation, anxiety, and headache 6, 1
  • A gradual taper over weeks to months is recommended for patients on high doses or long-term therapy 6

Drug Interactions

  • Fewer drug interactions compared to other antiepileptic medications 7
  • If taken with antacids containing aluminum and magnesium, wait at least 2 hours before taking the next dose of gabapentin 1

Special Populations

  • Requires dose adjustment in patients with renal impairment 6
  • Elderly patients may need lower doses and more gradual titration 6

Clinical Pearls

  • Despite being commonly prescribed for chemotherapy-induced peripheral neuropathy, evidence for this use is limited and conflicting 2
  • Insurance companies often require trial of gabapentin before allowing use of duloxetine for neuropathic pain, despite guidelines suggesting otherwise 2
  • The pharmacokinetic profile of gabapentin limits drug interactions, making it a good choice for patients on multiple medications 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Gabapentin for chronic neuropathic pain in adults.

The Cochrane database of systematic reviews, 2017

Research

Nonepileptic uses of gabapentin.

Epilepsia, 1999

Guideline

Gabapentin Withdrawal Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gabapentin: a unique anti-epileptic agent.

Neurological research, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.